STOCK TITAN

National Healthcare Properties: $531M Facility Sale

The purchaser’s certain termination rights ended September 25, 2026, while closing remains subject to customary conditions and is expected in the fourth quarter.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

National Healthcare Properties, Inc. (NHP) said that certain termination rights of the purchaser ended September 25, 2026, under an agreement for certain subsidiaries to sell the company’s portfolio of 40 outpatient medical facilities to an unaffiliated third party for approximately $531 million. The amount is before transaction expenses, property operating prorations, capital expenditure and other adjustments.

The purchase and sale agreement is dated July 15, 2026, and the transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions specified in the agreement.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Proposed sale price Approximately $531 million Before transaction expenses, property operating prorations, capital expenditure and other adjustments
Outpatient medical facilities 40 facilities Portfolio covered by the purchase and sale agreement
Purchase and sale agreement date July 15, 2026 Agreement among certain subsidiaries and an unaffiliated third party
Purchaser termination rights ended September 25, 2026 Certain termination rights under the agreement
Expected closing Fourth quarter of 2026 Subject to customary closing conditions
purchase and sale agreement financial
"under the purchase and sale agreement"
A purchase and sale agreement is a legally binding contract that spells out exactly what is being bought or sold, the price, who must do what, the timeline, and any conditions that must be met before the deal closes — like a detailed recipe and checklist for a transaction. Investors care because this document determines when ownership or assets change hands, what risks or obligations remain, and which conditions (financing, approvals, inspections) could delay, alter, or void the deal and therefore affect a company’s value and stock price.
property operating prorations financial
"property operating prorations and capital expenditure"
capital expenditure financial
"capital expenditure and other adjustments"
Capital expenditure is the money a company spends to buy, upgrade, or maintain long‑term physical items such as buildings, machinery, vehicles, or major software systems that it will use for years. It matters to investors because these investments shape future earnings and use up cash today — like a bakery buying a bigger oven to bake more bread; high or sustained spending can signal growth plans but also reduces short‑term cash and affects valuation and returns.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is NHP’s planned sale price for its outpatient medical facility portfolio?

Certain subsidiaries agreed to sell 40 outpatient medical facilities for approximately $531 million before transaction expenses, property operating prorations, capital expenditure and other adjustments. The purchaser is an unaffiliated third party.

When is the NHP facility portfolio sale expected to close?

The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions specified in the purchase and sale agreement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
FALSE000156103200015610322026-09-252026-09-250001561032us-gaap:CommonClassAMember2026-09-252026-09-250001561032hct:SeriesBCumulativeRedeemablePerpetualPreferredStockMember2026-09-252026-09-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): September 25, 2026
 
National Healthcare Properties, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Maryland001-3915338-3888962
(State or other jurisdiction
of incorporation)
(Commission File Number)(I.R.S. Employer
Identification No.)
 
540 Madison Ave., 27th Floor
New York, NY 10022
__________________________________________________________________________________________________________________________________________________________________________
(Address, including zip code, of Principal Executive Offices)

Registrant’s telephone number, including area code: (332) 258-8770
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common stock, $0.01 par value per shareNHPThe Nasdaq Global Market
7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per shareNHPBPThe Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨




Item 1.01 Entry into a Material Agreement

On September 25, 2026, certain termination rights of the purchaser terminated under the purchase and sale agreement (the “PSA”), dated as of July 15, 2026, as amended from time to time, by and among certain subsidiaries of National Healthcare Properties, Inc. (the “Company”) and an unaffiliated third party to sell the Company’s portfolio of 40 outpatient medical facilities for approximately $531 million (before transaction expenses, property operating prorations and capital expenditure and other adjustments). The PSA contains customary representations and warranties made by the parties thereto, customary covenants and agreements and customary post-closing obligations of the purchaser. The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions as specified in the PSA.

The foregoing description of the PSA is only a summary and is qualified in its entirety by reference to the full text of the PSA, a copy of which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026. Portions of the PSA may be omitted pursuant to Item 601(b)(10)(iv) or Item 601(a)(5) of Regulation S-K under the Securities Exchange Act of 1934, as amended.

Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.Description
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NATIONAL HEALTHCARE PROPERTIES, INC.
Date: September 28, 2026
By:
/s/ Andrew T. Babin
Andrew T. Babin
Chief Financial Officer and Treasurer

Filing Exhibits & Attachments

4 documents

Keep reading